Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.
about
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma.Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide.Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence.How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinions.Emerging trends in understanding chemotherapy-induced peripheral neuropathy.Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma.Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma
P2860
Q35200765-A8573B42-5422-430E-8460-D29E7C7945B6Q35904262-7E1C62CA-100D-483C-8103-875B89D1447DQ37726775-B068CCD3-312B-4901-97AA-425D9060F6EBQ37826427-2181C8A9-649A-4665-B96C-D2A5DEF2785BQ37862262-49A96A7B-1206-4448-95A9-AA58B2F2C39CQ38133440-C153D76E-0649-4C96-A890-BB4C7B3C80F4Q39584752-0033B042-E1F2-4E6B-92F8-0C4A59AB088DQ56982314-9875E698-3D91-4763-8856-A2020413C31A
P2860
Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Long-term outcome in relapsed ...... ing efficacy and side-effects.
@en
Long-term outcome in relapsed ...... ing efficacy and side-effects.
@nl
type
label
Long-term outcome in relapsed ...... ing efficacy and side-effects.
@en
Long-term outcome in relapsed ...... ing efficacy and side-effects.
@nl
prefLabel
Long-term outcome in relapsed ...... ing efficacy and side-effects.
@en
Long-term outcome in relapsed ...... ing efficacy and side-effects.
@nl
P2093
P50
P1433
P1476
Long-term outcome in relapsed ...... cing efficacy and side-effects
@en
P2093
Alessandro Corso
Anna Maria Cafro
Enrica Morra
Luciana Barbarano
Maria Teresa Petrucci
Mario Lazzarino
Patrizia Zappasodi
Silvia Mangiacavalli
Tommaso Caravita
P304
P356
10.1016/J.LEUKRES.2009.03.015
P577
2009-04-16T00:00:00Z